Mydecine Broadcasts First Quarter 2022 Monetary Outcomes and
DENVER, Could 16, 2022 (GLOBE NEWSWIRE) — Mydecine Improvements Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Firm”), a biotechnology firm aiming to remodel the remedy of psychological well being and dependancy issues, in the present day reported monetary outcomes and supplied a enterprise replace for the......